Free Trial

Harmony Biosciences (HRMY) Earnings Date, Estimates & Call Transcripts

$29.95
+0.60 (+2.04%)
(As of 05/24/2024 08:50 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 6Estimated
Actual EPS
(Apr. 30)
$0.67 Beat By $0.07
Consensus EPS
(Apr. 30)
$0.60
Skip Charts & View Estimated and Actual Earnings Data

HRMY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HRMY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Harmony Biosciences Analyst EPS Estimates

Current Year EPS Consensus Estimate:$2.53 EPS
Next Year EPS Consensus Estimate: $3.87 EPS

HRMY Earnings Date and Information

Harmony Biosciences last released its earnings data on April 30th, 2024. The reported $0.67 EPS for the quarter, topping analysts' consensus estimates of $0.60 by $0.07. The business had revenue of $154.62 million for the quarter, compared to the consensus estimate of $154.10 million. Its revenue for the quarter was up 29.8% on a year-over-year basis. Harmony Biosciences has generated $2.31 earnings per share over the last year ($2.31 diluted earnings per share) and currently has a price-to-earnings ratio of 13.0. Earnings for Harmony Biosciences are expected to grow by 52.96% in the coming year, from $2.53 to $3.87 per share. Harmony Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off prior year's report dates.

Harmony Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/6/2024
(Estimated)
------- 
4/30/2024Q1 2024$0.60$0.67+$0.07$0.67$154.10 million$154.62 million    
2/22/2024Q4 2023$0.74$0.45($0.29)$0.45$168.90 million$168.40 million    
10/31/2023Q3 2023$0.67$0.63($0.04)$0.63$147.83 million$160.30 million    
8/1/2023Q2 2023$0.62$0.56($0.06)$0.56$139.79 million$134.22 million
5/2/2023Q1 2023$0.44$0.48+$0.04$0.48$118.21 million$119.13 million
2/21/2023Q4 2022$0.54$1.01+$0.47$1.23$127.73 million$128.31 million
11/1/2022Q3 2022$0.10$0.95+$0.85$0.46$113.11 million$117.21 million
8/2/2022Q2 2022$0.40$0.57+$0.17$0.75$99.35 million$107.03 million    
5/3/2022Q1 2022$0.25$0.51+$0.26$0.67$87.77 million$85.31 million    
2/28/2022Q4 2021$0.32$0.63+$0.31$0.88$88.43 million$91.21 million    
11/8/2021Q3 2021$0.29($0.17)($0.46)$1.03$79.30 million$80.73 million  
8/9/2021Q2 2021$0.18$0.24+$0.06$0.84$70.85 million$73.82 million    
5/10/2021Q1 2021($0.03)$0.38+$0.41$0.63$59.60 million$59.67 million  
3/24/2021Q4 2020$0.09$0.25+$0.16$0.50$51.50 million$56.29 million  
11/17/2020Q3 2020($0.05)($0.14)($0.09)($0.14)$40.10 million$45.61 million  

Harmony Biosciences Earnings - Frequently Asked Questions

When is Harmony Biosciences's earnings date?

Harmony Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates. Learn more on HRMY's earnings history.

Did Harmony Biosciences beat their earnings estimates last quarter?

In the previous quarter, Harmony Biosciences (NASDAQ:HRMY) reported $0.67 earnings per share (EPS) to beat the analysts' consensus estimate of $0.60 by $0.07. Learn more on analysts' earnings estimate vs. HRMY's actual earnings.

How can I listen to Harmony Biosciences's earnings conference call?

The conference call for Harmony Biosciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Harmony Biosciences's conference call transcript?

The conference call transcript for Harmony Biosciences's latest earnings report can be read online. Read Transcript

How much revenue does Harmony Biosciences generate each year?

Harmony Biosciences (NASDAQ:HRMY) has a recorded annual revenue of $582.02 million.

How much profit does Harmony Biosciences generate each year?

Harmony Biosciences (NASDAQ:HRMY) has a recorded net income of $128.85 million. HRMY has generated $2.31 earnings per share over the last four quarters.

What is Harmony Biosciences's price-to-earnings ratio?

Harmony Biosciences (NASDAQ:HRMY) has a trailing price-to-earnings ratio of 12.97 and a forward price-to-earnings ratio of 11.84. The price/earnings-to-growth ratio is 0.52.

What is Harmony Biosciences's EPS forecast for next year?

Harmony Biosciences's earnings are expected to grow from $2.53 per share to $3.87 per share in the next year, which is a 52.96% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:HRMY) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners